186 related articles for article (PubMed ID: 38023709)
1. Genetically engineered nano-melittin vesicles for multimodal synergetic cancer therapy.
Zhang J; Liu X; Xia Y; Xu S; Liu X; Xiao H; Wang X; Liu C; Liu G
Bioeng Transl Med; 2023 Nov; 8(6):e10482. PubMed ID: 38023709
[TBL] [Abstract][Full Text] [Related]
2. Bee Venom Components as Therapeutic Tools against Prostate Cancer.
Badawi JK
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34067049
[TBL] [Abstract][Full Text] [Related]
3. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity.
Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125
[TBL] [Abstract][Full Text] [Related]
4. Development of D-melittin polymeric nanoparticles for anti-cancer treatment.
Lv S; Sylvestre M; Song K; Pun SH
Biomaterials; 2021 Oct; 277():121076. PubMed ID: 34461456
[TBL] [Abstract][Full Text] [Related]
5. Human scFv antibodies (Afribumabs) against Africanized bee venom: Advances in melittin recognition.
Pessenda G; Silva LC; Campos LB; Pacello EM; Pucca MB; Martinez EZ; Barbosa JE
Toxicon; 2016 Mar; 112():59-67. PubMed ID: 26829652
[TBL] [Abstract][Full Text] [Related]
6. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
[TBL] [Abstract][Full Text] [Related]
7. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.
Rady I; Siddiqui IA; Rady M; Mukhtar H
Cancer Lett; 2017 Aug; 402():16-31. PubMed ID: 28536009
[TBL] [Abstract][Full Text] [Related]
8. How Do the Properties of Amphiphilic Polymer Membranes Influence the Functional Insertion of Peptide Pores?
Belluati A; Mikhalevich V; Yorulmaz Avsar S; Daubian D; Craciun I; Chami M; Meier WP; Palivan CG
Biomacromolecules; 2020 Feb; 21(2):701-715. PubMed ID: 31855422
[TBL] [Abstract][Full Text] [Related]
9. Application of bee venom and its main constituent melittin for cancer treatment.
Liu CC; Hao DJ; Zhang Q; An J; Zhao JJ; Chen B; Zhang LL; Yang H
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1113-1130. PubMed ID: 27677623
[TBL] [Abstract][Full Text] [Related]
10. Anti-Tumor Effects of Melittin and Its Potential Applications in Clinic.
Lyu C; Fang F; Li B
Curr Protein Pept Sci; 2019; 20(3):240-250. PubMed ID: 29895240
[TBL] [Abstract][Full Text] [Related]
11. Nano-viscosimetry analysis of the membrane disrupting action of the bee venom peptide melittin.
Pandidan S; Mechler A
Sci Rep; 2019 Jul; 9(1):10841. PubMed ID: 31346251
[TBL] [Abstract][Full Text] [Related]
12. Lipid Headgroup Charge Controls Melittin Oligomerization in Membranes: Implications in Membrane Lysis.
Pal S; Chakraborty H; Chattopadhyay A
J Phys Chem B; 2021 Aug; 125(30):8450-8459. PubMed ID: 34254509
[TBL] [Abstract][Full Text] [Related]
13. Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles.
Jallouk AP; Palekar RU; Marsh JN; Pan H; Pham CT; Schlesinger PH; Wickline SA
Bioconjug Chem; 2015 Aug; 26(8):1640-50. PubMed ID: 26083278
[TBL] [Abstract][Full Text] [Related]
14. Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines.
Duarte D; Falcão SI; El Mehdi I; Vilas-Boas M; Vale N
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335887
[TBL] [Abstract][Full Text] [Related]
15. Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy.
Nguyen Cao TG; Kang JH; Kim W; Lim J; Kang SJ; You JY; Truong Hoang Q; Kim WJ; Rhee WJ; Kim C; Ko YT; Shim MS
Theranostics; 2022; 12(3):1247-1266. PubMed ID: 35154485
[TBL] [Abstract][Full Text] [Related]
16. Melittin-induced alterations in dynamic properties of human red blood cell membranes.
Watala C; Gwoździński K
Chem Biol Interact; 1992 Apr; 82(2):135-49. PubMed ID: 1314707
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.
Al-Ani I; Zimmermann S; Reichling J; Wink M
Phytomedicine; 2015 Feb; 22(2):245-55. PubMed ID: 25765829
[TBL] [Abstract][Full Text] [Related]
18. Interaction of bee venom melittin with zwitterionic and negatively charged phospholipid bilayers: a spin-label electron spin resonance study.
Kleinschmidt JH; Mahaney JE; Thomas DD; Marsh D
Biophys J; 1997 Feb; 72(2 Pt 1):767-78. PubMed ID: 9017202
[TBL] [Abstract][Full Text] [Related]
19. Bee venom in cancer therapy.
Oršolić N
Cancer Metastasis Rev; 2012 Jun; 31(1-2):173-94. PubMed ID: 22109081
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic Profiling of the Synergistic Effects of Melittin in Combination with Cisplatin on Ovarian Cancer Cells.
Alonezi S; Tusiimire J; Wallace J; Dufton MJ; Parkinson JA; Young LC; Clements CJ; Park JK; Jeon JW; Ferro VA; Watson DG
Metabolites; 2017 Apr; 7(2):. PubMed ID: 28420117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
